# Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

> **NCT05968885** · PHASE4 · RECRUITING · sponsor: **Mackay Memorial Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Urinary Bladder, Overactive
- Urodynamics
- Effect of Drug

## Interventions

- **PROCEDURE:** Intradetrusor Botox® (onabotulinumtoxinA) injection
- **DRUG:** Combine Mirabegron and Solifenacin.

## Key facts

- **NCT ID:** NCT05968885
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05968885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05968885, "Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05968885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*